Adagene
ADAG
11 hedge funds and large institutions have $15.8M invested in Adagene in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
156% more capital invested
Capital invested by funds: $6.16M → $15.8M (+$9.63M)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
10% more funds holding
Funds holding: 10 → 11 (+1)
5.8% more ownership
Funds ownership: 7.49% → 13.29% (+5.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$284K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.51M |
| 2 |
SVI
Strategic Vision Investment
Hong Kong
|
-$366K |
ADAG Hedge Fund Activity: Q4 2023 in Review
11 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Adagene (ADAG) for Q4 2023, worth a combined $15.8M — up 156% from $6.16M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ADAG positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $284K. The largest seller was Fidelity Investments, cutting an estimated $1.51M.
- 11 institutional investors held Adagene (ADAG) as of Q4 2023, up from 10 in Q3 2023.
- Funds reported $15.8M of Adagene stock for Q4 2023, up 156% quarter-over-quarter.
- 2 funds opened new Adagene positions in Q4 2023 and 1 closed out, a net change of +1 holder.
- The largest Adagene buyer in Q4 2023 was Morgan Stanley, an estimated $284K added.
- The largest Adagene seller in Q4 2023 was Fidelity Investments, an estimated $1.51M sold.
Based on aggregated 13F filings for Q4 2023.